December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Collegium Pharmaceutical, Inc. - Common Stock (NQ:COLL)

48.89 +1.63 (+3.44%)
Streaming Delayed Price Updated: 1:17 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Collegium Pharmaceutical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Collegium Publishes Inaugural 2022 Environmental, Social and Governance Report
Highlights 2022 environmental, social and governance achievements 
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium Pharmaceutical, Inc. Prices Upsized $210.0 Million Convertible Senior Notes Offering
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Analyst Sees This 'Specialty Pharma' Stock Stuck Until Prescription Trends Improve ↗
 
Via Benzinga
News headline image
Recap: Collegium Pharmaceutical Q1 Earnings ↗
Collegium Pharmaceutical (NASDAQ:COLL) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Why Collegium Pharmaceutical's Shares Are Trading Higher Today ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
It's time to start the day with a breakdown of the biggest pre-market stock movers investors will want to watch on Tuesday! 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Collegium Pharmaceutical, Inc. Announces Proposed Convertible Senior Notes Offering
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium Announces Fourth Quarter and Full Year 2022 Preliminary Financial Results
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium Provides 2023 Financial Guidance
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Appeals Court Affirms Validity of Collegium’s Belbuca® Patents
Ruling bars ANDA filer Alvogen from entering market until 2032 patent expiry 
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium to Participate in Piper Sandler 34th Annual Healthcare Conference
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium Reports Third Quarter 2022 Financial Results
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium to Report Third Quarter 2022 Financial Results on November 3, 2022
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022 ↗
  
Via Benzinga
News headline image
7 Micro-Cap Stocks to Take a Chance on Now ↗
Despite (or because of) their size, some micro-cap stocks, have good value and are overlooked and should be considered by investors. 
Via InvestorPlace
News headline image
A Preview Of Collegium Pharmaceutical's Earnings ↗
Collegium Pharmaceutical (NASDAQ:COLL) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
News headline image
5 Value Stocks To Watch In The Healthcare Sector ↗
What Defines a Value Stock? 
Via Benzinga
News headline image
5 Value Stocks To Watch In The Healthcare Sector ↗
What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E... 
Via Benzinga
News headline image
Analyst Ratings For Collegium Pharmaceutical ↗
Over the past 3 months, 4 analysts have published their opinion on Collegium Pharmaceutical (NASDAQ:COLL) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Tuesday ↗
JP Morgan raised Ralph Lauren Corporation (NYSE: RL) price target from $137 to $142. Ralph Lauren shares rose 1.2% to $124.00 in pre-market trading. 
Via Benzinga
News headline image
BDSI Stock Alert: The Deal Sending Little-Known BioDelivery Skyrocketing Today ↗
Today, a big takeover announcement has sent shares of BioDelivery and BDSI stock soaring more than 50% on investor enthusiasm for this deal. 
Via InvestorPlace
News headline image
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front... 
Via Benzinga
News headline image
32 Stocks Moving In Monday's Mid-Day Session ↗
Gainers BioDelivery Sciences International, Inc. (NASDAQ: BDSI) shares jumped 51.9% to $5.53. Collegium Pharmaceutical will acquire BioDelivery Sciences International at $5.60... 
Via Benzinga
News headline image
52 Biggest Movers From Yesterday ↗
Gainers BioDelivery Sciences International, Inc. (NASDAQ: BDSI) shares climbed 52.8% to close at $5.56 on Monday. Collegium Pharmaceutical will acquire BioDelivery Sciences... 
Via Benzinga
News headline image
Collegium Pharma Broadens Its Pain Portfolio With $600M BioDelivery Sciences Deal ↗
Collegium Pharmaceutical Inc (NASDAQ: COLL) will acquire BioDelivery Sciences International Inc (NASDAQ: BDSI) at $5.60 per share in an all-cash transaction,... 
Via Benzinga
News headline image
A Look Into Healthcare Sector Value Stocks ↗
What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E... 
Via Benzinga
News headline image
5 Value Stocks To Watch In The Healthcare Sector ↗
What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.